MISSOURI – The University of Missouri has developed the first vaccine for bovine anaplasmosis, a tick-borne disease affecting cattle. Led by Roman Ganta, a professor at Mizzou’s College of Veterinary Medicine, the research has resulted in a vaccine that could significantly benefit cattle producers.
Ganta’s team genetically modified the pathogen Anaplasma marginale to create a vaccine that provides protection for at least a month. Although the vaccine is not yet available, Ganta is working with industry partners to bring it to market.
Bovine anaplasmosis, transmitted by ticks and other vectors, causes severe symptoms such as anemia, jaundice, and decreased milk production. The disease costs the U.S. beef industry over $300 million annually. The new vaccine aims to help alleviate this financial burden and improve cattle health.
